Physiomics (PYC)

Sector:

Health Care

Index:

FTSE AIM All-Share

0.68p
   
  • Change Today:
    -0.025p
  • 52 Week High: 1.85
  • 52 Week Low: 0.63
  • Currency: UK Pounds
  • Shares Issued: 203.21m
  • Volume: 174,292
  • Market Cap: £1.37m
  • RiskGrade: 504
  • Beta: 0.48

Physiomics Overview

Physiomics’ vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -123.5% -89.7%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 2.5 1.9
Pr/Book 4.9  
Latest F'cast
Revenue -9.1% 33.5%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Physiomics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 0.80 (0.13) (0.09)p n/a n/a n/a n/a 0.0%
30-Jun-21 0.70 (0.34) (0.22)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.83 (0.36) (0.26)p n/a n/a n/a n/a 0.0%
30-Jun-23 0.60 (0.57) (0.49)p n/a n/a n/a n/a 0.0%
30-Jun-24 0.54 (0.67) (0.45)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Physiomics Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 0.73 (0.65) (0.34)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Physiomics Company Announcements

Result of AGM 19-Nov-2024 16:50 RNS
Director Dealing 08-Nov-2024 07:00 RNS
Senior Management Announcement 04-Nov-2024 07:00 RNS

Latest Physiomics Director Deals

Traded Action Notifier PriceAmountValue
07-Nov-24 Buy Peter Sargent 0.66p 459,090 £3,029.99

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Physiomics Market Data

Currency UK Pounds
Share Price 0.68p
Change Today -0.025p
% Change -3.57 %
52 Week High 1.85
52 Week Low 0.63
Volume 174,292
Shares Issued 203.21m
Market Cap £1.37m
Beta 0.48
RiskGrade 504

Physiomics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
37.81% below the market average37.81% below the market average37.81% below the market average37.81% below the market average37.81% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Price Trend
87.71% below the market average87.71% below the market average87.71% below the market average87.71% below the market average87.71% below the market average
72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average
Income Not Available
Growth
56.08% below the market average56.08% below the market average56.08% below the market average56.08% below the market average56.08% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

Physiomics Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
09:25 170,000 @ 0.69p
09:09 4,292 @ 0.70p

Physiomics Key Personnel

CEO Peter Sargent

Top of Page